Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 1,105 | 1,401 | 384 | 0 | 4,179 |
| Cost of Goods | 603 | 656 | 194 | N/A | 5,491 |
| Gross Profit | 502 | 745 | 190 | N/A | -1,312 |
| Operating Expenses | 26,008 | 32,685 | 22,165 | 24,593 | 20,676 |
| Operating Income | -24,903 | -31,284 | -21,781 | -24,593 | -21,496 |
| Interest Expense | 3,899 | 3,899 | 3,899 | 3,912 | 637 |
| Other Income | 182 | 1,298 | 2,340 | 2,808 | 659 |
| Pre-tax Income | -28,621 | -33,886 | -23,340 | -25,697 | -21,475 |
| Income Tax | N/A | N/A | -191 | N/A | N/A |
| Net Income Continuous | -28,621 | -33,886 | -23,149 | -25,697 | -21,475 |
| Net Income Discontinuous | -4,471 | -1,687 | -12,672 | -10,081 | N/A |
| Minority Interests | -1,681 | N/A | N/A | N/A | N/A |
| Net Income | $-31,411 | $-35,573 | $-35,821 | $-35,778 | $-21,475 |
| EPS Basic Total Ops | -315.03 | -401.29 | -442.54 | -442.54 | -266.28 |
| EPS Basic Continuous Ops | -270.03 | -382.54 | -285.03 | -318.78 | -267.41 |
| EPS Basic Discontinuous Ops | -45.00 | -18.75 | -157.52 | -123.76 | N/A |
| EPS Diluted Total Ops | -315.03 | -401.29 | -442.54 | -442.54 | -266.28 |
| EPS Diluted Continuous Ops | -270.03 | -382.54 | -285.03 | -318.78 | -267.41 |
| EPS Diluted Discontinuous Ops | -45.00 | -18.75 | -157.52 | -123.76 | N/A |
| EBITDA(a) | $-22,777 | $-29,030 | $-18,830 | $-22,652 | $-20,068 |